Brianna Jones, a student in the Project ENGAGES program at the Georgia Institute of Technology, was featured recently on Atlanta radio station WABE 90.1 FM, a National Public Radio affiliate.
Project ENGAGES (Engaging New Generations at Georgia Tech through Engineering & Science) is a high school science education program developed at the Petit Institute for Bioengineering and Bioscience at Georgia Tech in partnership with Coretta Scott King Young Women's Leadership Academy, B.E.S.T Academy, KIPP Atlanta Collegiate, Benjamin E. Mays High School, Charles R. Drew Charter High School and South Atlanta High School, six minority-serving public high schools in the City of Atlanta.
ENGAGES is co-directed by Manu Platt, associate professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, and Bob Nerem, professor emeritus of bioengineering and the founding director of the Petit Institute for Bioengineering and Bioscience at Georgia Tech.
Jones, a senior at Mays High School who works in the lab of Petit Institute Executive Director Andrés García through the ENGAGES program, was interviewed as part of WABE's coverage of the Google global science fair at King Plow Arts Center on Friday. You can read and listen to the story here.
Media Contact
Keywords
Latest BME News
Researchers demonstrate stem cell treatment without chemotherapy and painful bone marrow procedure
BME researchers explore the critical role of mechanical force in rare genetic disorder
Researchers develop spatial transcriptomics toolkit that provides new insights into the molecular processes of life
Air Detectives take top prize to give department three straight victories in Expo competition
Coulter BME community gathers at the Fabulous Fox to celebrate anniversary of unique public-private partnership
Coskun pioneering new research area and building a company around iseqPLA technology
BME undergraduate student and competitive skater Sierra Venetta has found success on and off the ice
BME researcher Ankur Singh using new technology to uncover weakened response in cancer patients